The resolution expresses support for designating April 2026 as "Parkinson's Awareness Month," highlighting that Parkinson's disease affects over 1,000,000 individuals in the U.S. and is the second most common neurodegenerative disease globally. It acknowledges the disease's varied symptoms, unknown exact causes, and its significant impact on patients and caregivers. The Senate resolves to support the goals of this awareness month, including continued research for better treatments and a cure. It recognizes individuals participating in vital clinical trials and commends the dedication of organizations, volunteers, and researchers. These efforts aim to improve the quality of life for those living with Parkinson's disease and their families.